|
|
comments (0)
|




Ingredients of egg whites:
8 egg whites
½ tsp cream of tartar
90 gm caster sugar
|
|
comments (0)
|
In response to these safety hazards, it claims it has developed a new method for rapid detection of potential bacterial pathogens in cannabis-infused cookies and cannabis flowers with its MicroSnap bioluminescence technology.
The way MicroSnap bioluminescence works is like a swab, generating light when enzymes characteristic of the target bacteria react with specific molecules in a test. Light reactions are then quantified as RLUs (Relative Light Units), which can determine any possible contamination over a threshold value determined by the tested substances.
Hygiena released the results of a study at the International Association for Food Protection (IAFP) in Louisville, Kentucky, where it showed how MicroSnap can detect Enterobacter, Coliform and Total Viable Count bacteria within five hours in spiked samples of cannabis flowers and infused edible cookies.
Brandon Katz, research scientist, Hygiena, said by reading the results in an EnSURE or SystemSure machine for relative light units the process is easier than PCR (Polymerase Chain Reaction), cell culture, or WGS (Whole Genome Sequencing).
“Our study shows rapid microbiological methods can be successfully applied to the growing cannabis food industry,” said Katz.
“We are excited to be able to announce these positive findings and provide a technology which can reduce contamination hazards in cannabis processing.”
Hygiena’s MicroSnap products (separate ones for E. coli, coliform, Enterobacter, and total viable count) have been around since 2012 and are used in a number of food settings. They were AOAC verified in 2012-2013 and the latest method and study is focusing on cannabis-infused food.
Katz claims now is the time to invest in technology in this area because the cannabis-infused food and beverage market is growing. Some US states have already released certain safety regulations and the US FDA has begun to regulate hemp-related products for safety. According to recent market research studies, Europe's cannabis and CBD markets are set to continue growing 'exponentially' over the next few years and regulators in Europe are now taking a closer look at the market for foods and cosmetics which contain CBD.
Even though cannabis has a diverse microbiome of beneficial microbes that do not harm humans, the legalization of cannabis in certain countries worldwide has led to a need for more rapid testing of products and it is necessary to determine minimum threshold values that indicate safety.
Hygiena MicroSnap study
As an example, UK sweet expert Andy Baxendale is working with confectionery manufacturer Sweetdreams to produce products combining cannabis derivative CBD oil with milk, white or dark chocolate coatings, including: solid dark chocolate balls, malt balls (Malteser type products), almonds, goji berries, cranberries, honeycomb and yoghurt coated fruits.
The work is continuing on an ongoing basis as the demand is constant for these type of products at the moment and chocolate is an easy medium for people to eat, especially if they feel that their “naughty” treat can somehow now benefit from CBD oil.
Speaking about Hygiena’s announcement, Baxendale said this type of technology has been in use for several years in the food industry to detect when equipment has been insufficiently cleaned, so it appears to be a useful extension of that technology.
“However, the cleaning application provided an instant reading – this method (MicroSnap) appears to take significantly longer and in actual fact is not that much quicker than traditional microbiological methods,” he added.
“It will certainly provide an alternative to tests available via microbiological laboratories, but to become widely accepted it will have to be validated and verified by food regulation authorities.”
In terms of higher risk products that contain unprocessed cannabis varieties, Baxendale said the MicroSnap bioluminescence technology will cut down the time needed to verify a product safety.
“In the case of confectionery products that utilise mainly processed cannabis extracts – for example THC or CBD, the processing of the additions combined with the inherent product safety of goods (stemming from high sugar content and low water activity) renders these products extremely safe in terms of microbial activity, so the traditional tests are fine – if one of the new tests were needed it would only be the TVC test – typical values for sugar or chocolate confectionery are less than 100cfu/g rendering them virtually sterile,” he said.
On the beverage side, CBD contenders in the drinks industry include Coke which admitted it is “closely watching” the growth of CBD, as an ingredient in what it called “functional wellness beverages”; Constellation brands, which owns Corona beer, Svedka vodka and Casa Noble tequila, is investing an additional $4 billion in the Canadian cannabis company Canopy Growth; Lagunitas has launched a cannabis infused drink using THC and CBD and Cannawine is now on the market.
Dan Hooper, director, client services, drinks marketing specialists YesMore Agency, said from a brand’s point of view, it may be a good idea to track some crops, as we start to see cannabis being used in consumables within big companies like Lagunitas and Heineken.
“There’s a benefit in some sort of guarantee to make sure the THC/CBD they place in their drinks is sourced from reputable sources, especially as they operate across markets where the legal status of the product varies. So there’s clearly something here that may appeal to many brands,” he said.
“However, from a consumers’ perspective, I wonder if this will change as the market matures and cannabis becomes like any other ingredient. And I wonder how much this sort of tracing technology will matter to consumers - they may feel reassured by simply buying products from a reputable brand - or it may turn them off.”
Hooper added, with any new development in the market, there’s always an influx of creative solutions. But he does not know if there will be an influx of products like Hygiena’s MicroSnap bioluminescence.
“Whilst this technology is innovative, there may be less complex or invasive ways to track the cannabis as it makes its way into products, which may be as appealing. There are other models here - for example the way that we certify Fairtrade, or the Soil Association in the UK verifies organic ingredients. It may come down to simply having a trade body that regulates and certifies producers. This would not discriminate against smaller or artisan producers for whom there may be a cost barrier to implementing technology like this.
“In both of these processes (organic and fair trade), consumers trust the producer to manage that supply chain. I would be interested to know how the price of schemes like these stacks up against this new technology - especially when you factor in the price premium that organic (and similar) products can command.
“On the subject of ethical concerns - tagging in this way doesn’t in and of itself tackle other issues that consumers are concerned about - things like ethical or organic production. It might sound crazy to be talking about organic cannabis, but there’s no reason why a consumer who chooses organic or Fairtrade products in other areas of their life wouldn’t want to do the same with cannabis.
“In addition: the technology is complex, and not well understood by the general public. There are definitely communications issues around this sort of tracking molecule - which can obviously be consumed. We know this information will be supplied digitally to 'appropriate stakeholders' so there need to be some clear comms around when the tracking stops."
Ultimately consumers need to feel reassured that their consumption of these products is not being monitored.
“I can see positives for brands, though I question whether something like this is entirely necessary at this stage - it would make cannabis unique in the food chain for this sort of monitoring and there are other systems which may be better received by the public. I also wonder whether the perceived ‘need’ for this may decrease as cannabis consumption becomes legitimised.”
Infused By Epic is one example of company that specialises in targeted delivery of CBD and other phytocannabinoids (delivered as a water soluble nanotechnology, available in liquid and powder form), making it easier for manufacturers to formulate Nano CBD ingredients into their existing product lines and create new ones.
When mixed into any food or beverage, Infused by Epic is a ‘raw ingredient’, delivering the higher bio-availability and faster onset to the consumer for mitigation of things like pain, anxiety and sleeplessness.
Kalon Baird, COO, Infused By Epic, told FoodNavigator Hygiena’s technology is very interesting and novel from a consumer safety standpoint, and for use by manufacturers to spot-check their infused products before mandatory compliance testing.
“It’s standard for many manufacturers in the cannabis space, and less so in the CBD space, to conduct R&D testing before final distribution. This technology would allow for spot ‘R&D testing’ that could save thousands in avoidance of a potentially failed/non compliant batch,” he said.
“Once an infused batch is manufactured, it’s very hard to remediate for items such as pesticide, or microbial contamination, especially as is the case for edibles. We would be excited to apply this technology to our water soluble Nano emulsions prior to final certificate of analysis, to give us additional insurance.
“We are also excited about the opportunities for other manufacturers to get compliant product on shelves with less headaches. Cannabis has the highest compliance and testing requirements of any consumer product known. Any additional measures which can be taken up front will save time, money, and empower users to run their business more efficiently. Assuming that the test is cost competitive with state lab fees.”
Serge Chistov, financial partner, Honest Marijuana Company, utilises all-natural cultivation methods to produce organic and eco-conscious cannabis products including its recently-patented Nanobidiol Technology including THC capsules and Hemp Theory hemp oil extract tincture, infused honey, gummies, and pain relief cream.
Chistov agrees cannabis companies run higher risks because there is less regulation in the supply chain and less regulation in growing standards.
“There is also a lack of uniform agricultural regulations, different genetics, and inconsistent growing environments and lack of regulations regarding the water quality,” he said.
“The only thing that is regulated is the final product, so if the final product can pass the limited regulations depending on the market, then it's golden. Then, whichever way you grew it was okay, as long as it went through the final go-ahead.
“That follows with any agricultural product, there are standard operating procedures for writing and preparing the water, fertilizers, soil, etc., and it is more or less uniform and easier to control. I do believe due to the lack of uniformity in the cannabis industry's growing, curing, conducting, and transportation techniques, the product probably runs more risk to be less uniform. Because of that, there is more risk for it to potentially contain some harmful, unwanted subjects.”
Talking about the consequences of consuming contaminated cannabis products Chistov added: “We need to start with the fact that before we knew about the product being contaminated or potentially contaminated, we just consumed it. We would call our dealer and even today, you probably don't call your dealer to ask about whether the product is contaminated. You just ask him what he has, how much he has, and when you can see him.
“This is how business is done in a majority of the cannabis market in the United States right now. The black market is still a predominant source of cannabis in the US, so, obviously, there is no testing, verification, or uniformity, and there is not even enforced post-harvest testing.”
He said mold is the most dangerous contaminant and some of the residual pesticides that can be left by poor agricultural growing processes. That is the other extremely dangerous, potentially harmful contaminant, especially due to the fact that the majority of cannabis consumed is through combusting it - we increase the temperature and that creates the chemical combustion that no one can quantify or even imagine.
“The message here needs to be for the quickest legalization and uniformity so we can bring this crop alongside any other agricultural crops to be uniform, controlled, properly cared for, cured, transported and tested,” he added.
The only ways cannabis companies can keep bacteria and other contaminants out of their products is simple cleanliness, said Chistov.
“The human body generates quite a bit of dirt, so it is essential to have proper gear in the growing process and regular food standards like 'the employee must wash hands upon returning to work'. It's just basic common sense of the food enterprise. We're not pretending to be clean room, sterile manufacturers. A common sense in production and the general rules of proper conduct in food manufacturing facilities should be followed. That would drastically reduce the potentials,” he added.
“Another aspect is the quality of the growers who control the pesticides and follow proper growing techniques. My advice to any grower is to try to not get into trouble so you have to use dangerous substances to deal with them. Try to plan for your process and use more beneficial bacteria and beneficial products to create a proper quality, uniform, final material that ends up with the consumer.”
He added, the industry is maturing and there will be new products and the same rules will apply to cannabis as they would for other products. Hemp extract and other cannabinoids will also play a role in dietary supplements and overall consumption will be extended with the new generation of products.
“In the future seniors and soccer moms will become bigger consumer groups in the cannabis industry. Older people who had a stigma are slowly but surly catching on with cannabis, with the societal changes that are changing that stigma. With soccer moms, right now there is a big conversation about more delivery services in the industry, which may take away the stigma of going into the pot shop and associating with the unknown element," said Chistov.
He added, there will be a new generation of edibles and topicals such as cannabinoids into nano-size so they can be added into transdermal patches, topical lotions, and more for the cleanest, most efficient, healthiest, and most discreet cannabis consumption.

|
|
comments (0)
|
What to bring to the meat-heavy barbecue, when everyone's noshing on fried chicken, hot dogs, and ribs? Try these easy, meat-free dishes. Fresh, light, and perfect for any summer potluck, they'll wow meat-eaters and vegans alike!

|
|
comments (0)
|
Stephen Zieminski founded Naked Nutrition five years ago. “The brand is about taking something that should be simple, like ‘hey if I want to buy whey protein, why can’t I just buy whey protein,’” he told us.
When Naked Nutrition launched “most things in the market had 15 plus ingredients and crazy flavors and all these kinds of sweeteners and stuff,” he recalled.
It’s rare to see a Naked Nutrition product’s ingredient list go above five items. The original line-up of protein powders it launched with—Naked Whey, Naked Pea, Naked Rice, Naked Casein, and Naked Goat (we’ll get to this one later) all feature just one ingredient.
Before starting his own business, Zieminski lived in Manhattan doing mergers and acquisitions tax work for a Big 5 firm, and then at the Royal Bank of Canada’s investment banking group.
Nutrition and supplementation have long been an interest of his. He ran track and cross-country in college and started weight lifting while he was in law school.
Protein and creatine supplementation became part of his routine, and that’s when he noticed a gap in the market for simpler supplements.
“The analogy I use is: Farmer’s markets are becoming more and more popular, people want to know ‘this is where the vegetables came from, this is where the honey came from.’ Why aren’t supplement companies telling you where the products are coming from?” he said.
He decided he wanted to be his own boss and start a company.
He bootstrapped the Naked Nutrition with his own savings (“Back in 2014, Kickstarter and that kind of stuff was fairly new-ish”).
Now living in Miami, Zieminski runs Naked Nutrition from wherever he wants.
“It’s fortunate enough that I can do my work from pretty much anywhere,” he said. “I tend to work while I travel just because I like it.”
In the coming weeks, Zieminski is diversifying his brand’s portfolio by adding single-serve products, namely a line of protein bars and single-serve meal shakes. He thinks these launches will open up the brand to a new audience.
“The single-serve and convenience model is picking up,” he said. “With protein powders, there’s only a certain subset of the population that would use them. Protein bars hit a much larger demographic.”
This expansion into single-serve and RTE (that’s ‘ready-to-eat’ in industry speak) reflects an overarching trend in the sports nutrition space. Established brands like Optimum Nutrition are aggressively adding to their RTE line-ups, even tapping the convenience store channel as an important source of revenue.
“It really is what people like, so why not?” Zieminski added.
Naked Nutrition isn’t alone in the sports nutrition set with a clean label proposition. There’s Ascent, which has nationwide distribution with Whole Foods Market for its free-from artificial ingredients protein powders. There’s also the plant-heavy brand Too Fit, which just joined PepsiCo’s inaugural Greenhouse Nutrition incubator.
Even big players like Gatorade are embracing the clean-label trend by launching ESSNTL, which has no added sugar or artificial flavors and colors.
Zieminski said that, even with more competition, his brand has a ‘first-movers advantage.’
“I’ve been doing this for over four years now, so we have a bigger audience and bigger reach than any other start-up,” he said. “So they’re working in an entirely different environment than I was working with in 2014.”
Simplicity and transparency are the keywords that Zieminski wanted his brand to communicate. The tubs are transparent, allowing buyers to see the powder even before opening packaging.
There’s also the minimalist packaging design that, contrary to category convention, isn’t heavy on claims or neon colors or exclamation marks.
“The labeling, the branding, it’s so simple, we’re not shooting for an 18-year-old kid that just got into weight lifting or a 35-year-old mom that does yoga,” he said. “We created a blank canvas, and the buyer uses it however they want.”
Zieminski is also relying on quirkiness. Goat whey powder was one of the first products in the company’s line-up because it helped the brand get under people’s radar.
“If you are a vegetarian you can still take milk-based products, but a lot of people just generally have an issue with lactose, so the lactose in goat’s milk behaves much differently than it does in cow’s milk,” he explained. “So you won’t really get that bloating or stomach upset with goat’s milk as you would with cow’s milk.”
“The hard part is with goat is that it’s a niche product. Goat’s milk is not produced anywhere near the volume that cow’s milk is,” he added.
“For that reason keeping goats is just that much difficult and the pricing of goat’s milk is higher. But at the same time, because there were very few people offering it, it was a fun way to get on people’s radar.”

|
|
comments (0)
|
|
|
comments (0)
|
Vitamin D is crucial to the overall health of the body, as it helps to keep muscles, bones and teeth healthy, said the NHS. The vitamin is needed to regulate the amount of calcium and phosphate in the body. A lack of vitamin D can lead to serious complications, including osteomalacia, rickets, or some deformities. You could be at risk of a vitamin D deficiency if you are constantly feeling tired, it’s been revealed.
Most people feel tired at some point if they aren’t getting enough sleep, or if they’re spending a lot of time at work.
But, your fatigue could be caused by a vitamin D deficiency if you’re still feeling tired despite having plenty of sleep, said medical website Medical News Today.
It’s likely to be caused by the condition if it’s accompanied by muscle weakness and chronic pain, it added.
“Vitamin D deficiency occurs when a person either does not consume enough vitamin D or when their body cannot absorb and metabolise the vitamin D they do consume,” it said.
“Many people with a vitamin D deficiency may have no symptoms or may go many years without experiencing symptoms.
“The symptoms of vitamin D deficiency can be vague, may change over time, and are similar to symptoms of a wide range of ailments.
“People who experience symptoms of vitamin D deficiency, or who have unexplained illnesses or nutritional deficiencies, should request a test for vitamin D deficiency.
“Some symptoms of a deficit in vitamin D include exhaustion, even with enough sleep.”
Exhaustion, or feeling tired all the time, is one of the most common reasons for people to see their GP, added the NHS.
Other than a vitamin D deficiency, it could be caused by stress, emotional shock or anxiety.
You should speak to a doctor if your tiredness goes on for a long time, or if it’s affecting your every day life.
The most common vitamin D deficiency symptoms include feeling very tired, getting sick more often than normal, and having a number of aches and pains.
But you could top up on vitamin D by taking supplements. During the winter months, it’s recommended that everyone takes a 10mcg supplement every day.
That’s because the sun isn’t strong enough for the body to naturally make enough vitamin D.
Alternatively, you could try adding more vitamin D-rich foods to your diet. The best food sources of vitamin D include oily fish, eggs, mushrooms, and some fortified products.
Speak to a doctor if you’re worried about the signs or symptoms of a vitamin D deficiency.

|
|
comments (0)
|
FDA’s commissioner signaled he is willing to work with members of Congress on a legislative solution that would allow CBD (cannabidiol) to be sold in conventional food and dietary supplements if his agency determines a rulemaking process would be too onerous.
During a congressional hearing Wednesday, Scott Gottlieb, M.D., reiterated a rulemaking process would not be “straightforward.”
FDA has determined CBD presently cannot be added to food or sold in dietary supplements because the compound has been the subject of substantial clinical investigations made public—namely drug trials by GW Pharmaceuticals plc.
Although FDA has statutory authority to carve out a market for CBD in food and supplements through a rulemaking, such a proceeding could be mired in complexities and take years to complete.
“There’s not a good proxy for us doing this through regulation, and if we get comments back and find that this is sufficiently complicated for the agency, we will come back and have a discussion with Congress about how we might be able to work together on this,” Gottlieb said in testimony Feb. 27 before the House Committee on Appropriations.
In an exchange with Gottlieb, Rep. Chellie Pingree, a Democrat from Maine, emphasized “the need for some sense of urgency around” CBD. She and other lawmakers pointed out how widely available the compound is today despite FDA’s current position that it can’t be sold in food and supplements.
“My own state legislature is working on legislation around it right now, but the role of the FDA confuses everyone,” Pingree said. “I guess I’m wondering about how soon you can do this. Are there resources available, or do you need further assistance to get this done?”
Gottlieb responded, “We’re deeply focused on this.”
He acknowledged the challenge ahead and disclosed plans to convene a working group within his agency to examine the issues. During the hearing, Gottlieb also announced plans to hold a public meeting in April to solicit feedback.
“If we make a determination that the pathway here is going to be a multi-year regulatory process that could take two, three [or] four years, I will come back to Congress and have a discussion about whether or not there are other frameworks that could help address this,” he said.
Rep. Mark Pocan, a Democrat from Wisconsin, asked Gottlieb about a timeline for a rulemaking and whether it planned to work with USDA on regulations following the passage of the 2018 Farm Bill.
The Farm Bill removed hemp from the Controlled Substances Act, but it also preserved FDA’s authority to enforce the Federal Food, Drug & Cosmetic Act (FDCA)—the same law that, according to FDA’s interpretation, prohibits CBD in food and supplements based on the clinical investigations.
“We heard Congress loud and clear with respect to that legislation [Farm Bill], and I understand Congress wants there to be a pathway for CBD to be available,” Gottlieb acknowledged.
The commissioner raised a hypothetical in which CBD could be sold in food and supplements but remain distinguishable from pharmaceutical-grade CBD.
He cited the example of a pharmaceutical product containing a “high concentration” of CBD and a food or supplement containing a different concentration of CBD “because we want to preserve the incentive to study CBD as a pharmaceutical product.”
Later in the hearing, Gottlieb reiterated he wanted to preserve such an incentive for the pharmaceutical industry while recognizing Congress’s intent for CBD to be available in other forms.
In June, FDA approved the first CBD medicine in the United States, Epidiolex, for the treatment of seizures associated with rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome. GW Pharmaceuticals had been working for years to bring the drug to the U.S. market.
In a Feb. 26 statement regarding its financial results, GW Chief Executive Justin Gover said the company was “pleased” with “the high level of physician and patient demand for Epidiolex, and by the number of payors that have already made favorable coverage determinations for the product.”
GW did not immediately respond to a request for comment on Gottlieb’s remarks for this article.
Gottlieb suggested the possibility of a rulemaking distinguishing CBD products based on concentrations, formulations and other thresholds.
“That might or might not be something we can do in regulation,” he said. “We might need statute that either addresses this as a whole framework or addresses CBD specifically. If that’s the case, we will work through a process to have a discussion around that.”
The commissioner’s statements were very encouraging, said Jonathan Miller, an attorney in Lexington, Kentucky who serves as general counsel to the U.S. Hemp Roundtable. The U.S. Hemp Roundtable is a coalition of hemp companies whose members include marketers of CBD in dietary supplements.
Gottlieb “has received the message loud and clear from the Congress that Americans are demanding a clear and predictable regulatory path for the retail sale of hemp-derived CBD,” said Miller, a member of Frost Brown Todd LLP, in an email. “We are hopeful that the FDA will move quickly on this front, and the hemp industry stands by to participate.”
Stuart Tomc is vice president of human nutrition with CV Sciences Inc., the marketer of Plus CBD Oil. Plus CBD Oil is one of the leading brands of hemp-based CBD in the United States based on CV Sciences’ revenues and third-party research.
Tomc highlighted the need for FDA to oversee a category of hemp-derived CBD products that he said is resonating with millions of Americans.
“However, this emerging industry lacks FDA oversight with only a subset of responsible companies doing what it takes to ensure safe and high-quality product,” he said in an email.
CV Sciences, Tomc added, appreciated the commissioner’s “commitment to public health and his recognition that both Congress and the public want FDA regulation of hemp-derived CBD products.”
Rend Al-Mondhiry, an attorney in Washington who counsels clients on CBD, said she considered Gottlieb’s statements a “positive development” for the industry.
“The commissioner confirmed that finding a regulatory pathway for CBD is a high priority for FDA, and he recognizes that notice-and-comment rulemaking may not be the most efficient way to achieve this,” Al-Mondhiry, senior counsel with Amin Talati Upadhye LLP, said in an email. “His statements go a long way in addressing the concern that this issue could take years to resolve, but now it’s looking like that may not be the case.”
She planned to closely monitor the idea of establishing concentration limits or other restrictions.
Gottlieb’s statements regarding CBD reflect a commitment by the commissioner and his agency to devote “relatively scarce agency resources directly to CBD regulation,” said Jason Sapsin, a former associate chief counsel to FDA who practices law in Boulder, Colorado. “It’s also an explicit acknowledgment of the enormous political pressure FDA faces.”
But Sapsin said FDA is limited in what it can do based on statutory requirements that bind the agency.
“Absent an explicit statement that the agency will exercise sweeping enforcement discretion (which is already implicitly the status quo), the agency can’t move quickly unless it is willing to jeopardize longstanding policies and interpretations of the FDCA,” said Sapsin, counsel with Faegre Baker Daniels LLP, in an email. “Perhaps the closest it could come to addressing public health policy concerns would be quickly to convene one or more expert panels to review available data on CBD and determine whether there can by any agreement on ‘safe’ levels for specific products and populations.”
The latter move, the lawyer said, could lay the groundwork for FDA to reasonably exercise “enforcement discretion to provide short-term relief.”
Meanwhile, the hemp industry is looking forward to engaging with FDA as it closely examines a potential regulatory framework for what has become the hottest ingredient in the natural products industry.
“We … look forward to participating in the FDA rulemaking process and clarifying industry's obligation to invest in the science, safety and regulatory compliance for hemp-derived CBD dietary supplements,” Tomc of CV Sciences said. “Consumers expect that what is on the label is in the bottle, and without FDA regulation, it is far too easy for bad actors to take advantage.”
Editor's note: If you are attending the Natural Products Expo West in Anaheim, California, don't miss the all-day CBD summit on March 5. In the late afternoon, attorneys Jonathan Miller, Jason Sapsin and Rend Al-Mondhiry will explore legal issues around the cannabis-based compound—including FDA Commissioner Scott Gottlieb's recent comments reported above.
Learn more about the state and future of hemp CBD in NBJ’s Hemp and CBD Guide: Navigating Risks and Opportunities in a Complex Market. This comprehensive guide features full results from proprietary consumer and manufacturer surveys, New Hope Network Concept Lab analysis of delivery formats, science and regulatory updates and many more insights into this controversial market.
This piece originally appeared on Natural Products Insider, a New Hope Network sister website. Visit the site for more information on the global nutrition industry.

|
|
comments (0)
|
Natural News is about to begin releasing lab test results for off-the-shelf food, supplement and pet food products, covering heavy metals, nutritive minerals, pesticides and herbicides. These details will be released exclusively to Natural News email newsletter subscribers (FREE) and will NOT be publicly posted on the website. To be alerted, join our free email newsletter now, and watch for lab test results in the weeks ahead.
Enter your email address below to subscribe to our email announcement list (but don't use gmail). Your privacy is protected and you can unsubscribe at any time. If you don't join our email list, you may never see our valuable content again via Facebook, Google or YouTube. CENSORSHIP has now reached EXTREME levels across the 'net. The truth is being suffocated. Subscribe now if you want to escape the delusional bubble of false reality being pushed by Google and Facebook.

|
|
comments (0)
|
Statistically Significant Omega-3 Results from
Pre-specified Secondary Outcomes and Subgroup Analyses
p <0.05 for the association to be probable
Smaler p = more probable

|
|
comments (0)
|
Always wanted to try an exciting new activity, but just not sure where to start? We’re trying out the latest, greatest sports and activities for you and reporting back with our findings, so you know exactly what to expect when trying something for the first time. We tried everything from parkour to trail running and learned the basics straight from experts — and now we’re passing their secrets on to you. So go on, try that new sport for the first time… it probably won’t be your last.
